Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Question for the brainiacs.....

<< Previous

Bullboard Posts

Next >>

Comment by skier59on Feb 16, 2022 4:08pm

302 Views

Post# 34435251

RE:RE:Question for the brainiacs.....

I thought I read somewhere they would get the 2nd dose after 6 months. Which according to my calculations, they should have right now, I think a 90 day result due now, on a follow up to their 2nd treatment. This actually can be a very important data group, as for sure hospitals will screw up first treatments along the way. How effective is the 2nd dose after 6 months?

Things that make you go hummmmmm?

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant